Pharmaceuticals & Biotech Canadian Companies

Simply Solventless Concentrates

Market Cap: CA$43.3m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Thiogenesis Therapeutics

Market Cap: CA$43.6m

A clinical-stage biopharmaceutical company, develops thiol-based therapeutic compounds to treat unmet pediatric medical needs.

Defence Therapeutics

Market Cap: CA$44.3m

Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.

Rubicon Organics

Market Cap: CA$44.3m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

FLUENT

Market Cap: US$38.0m

Through its subsidiaries, cultivates, manufactures processes, distributes, and sells medical cannabis products for medical and adult-use markets in Florida, New York, Pennsylvania, and Texas.

ZYUS Life Sciences

Market Cap: CA$53.9m

Manufactures and distributes cannabinoid-based therapeutics and product candidates in Canada, the United States, Australia, and the European Union.

Sernova Biotherapeutics

Market Cap: CA$57.5m

Operates as a clinical-stage biotechnology company in Canada.

InnoCan Pharma

Market Cap: CA$61.4m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

Covalon Technologies

Market Cap: CA$65.8m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

C21 Investments

Market Cap: CA$67.1m

An integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States.

NurExone Biologic

Market Cap: CA$67.6m

A pharmaceutical technology company, develops a platform for biologically guided exosome-based therapies for the treatment of central nervous system injuries.

iAnthus Capital Holdings

Market Cap: CA$67.8m

Owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.

Vext Science

Market Cap: CA$68.1m

Through its subsidiaries, provides integrated agricultural technology, services, and property management services in the cannabis industry in the United States.

Sona Nanotech

Market Cap: CA$72.2m

Operates as a nanotechnology life sciences company.

TRUBAR

Market Cap: CA$73.3m

Operates as a consumer products company with diversified assets in the plant-based and wellness consumer product categories in Canada.

Decibel Cannabis

Market Cap: CA$75.0m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

MTL Cannabis

Market Cap: CA$83.1m

Through its subsidiaries, engages in the cultivation and production of cannabis products for recreational and medical purposes in Canada.

Quantum BioPharma

Market Cap: CA$88.1m

Operates as a biopharmaceutical company.

Medicenna Therapeutics

Market Cap: CA$90.9m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Atlas Energy

Market Cap: CA$97.6m

A biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States.

Medexus Pharmaceuticals

Market Cap: CA$98.5m

Operates as a pharmaceutical company in Canada and the United States.

Onco-Innovations

Market Cap: CA$100.4m

A pre-clinical stage biotechnology company, develops drug candidates for cancer treatments.

Helix BioPharma

Market Cap: CA$103.9m

Operates as an immune-oncology company in Canada.

Satellos Bioscience

Market Cap: CA$105.8m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

ME Therapeutics Holdings

Market Cap: CA$118.4m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

BioNxt Solutions

Market Cap: CA$122.4m

Engages in research, development, manufacture, and sale of next generation drug formulations and delivery systems in Austria, Germany, and Switzerland.

Cardiol Therapeutics

Market Cap: CA$124.3m

A clinical-stage life sciences company, focuses on the developing of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases.

Planet 13 Holdings

Market Cap: CA$126.9m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

BioSyent

Market Cap: CA$135.9m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Grown Rogue International

Market Cap: CA$154.7m

A craft cannabis company, focuses on premium flower and flower-derived products.

HLS Therapeutics

Market Cap: CA$168.3m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Theratechnologies

Market Cap: CA$204.6m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Auxly Cannabis Group

Market Cap: CA$205.5m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

NervGen Pharma

Market Cap: CA$264.5m

A biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease.

Eupraxia Pharmaceuticals

Market Cap: CA$266.8m

A clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need.

Organigram Global

Market Cap: CA$317.0m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.